Results 141 to 150 of about 719 (168)

Applications and limitations of AI tools in enzyme design

open access: yesProtein Science, Volume 35, Issue 8, August 2026.
Abstract Enzymes catalyze various different chemical reactions often with high efficiency and selectivity compared to synthetic catalysts. Advances in protein engineering over the past decades have allowed researchers to design enzymes, improving their catalytic performance and adapting them for specific or entirely novel chemical reactions.
Rosa Teijeiro‐Juiz   +6 more
wiley   +1 more source

A Tale of Two Cell Lines: Characterization of Differential Efficacy of Small Molecule Drugs Cediranib and NU‐7441 on Primary Versus Metastatic Colorectal Cancer

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
ABSTRACT Colorectal cancer is recognized as one of the leading causes of cancer death amongst both sexes in the U.S. Despite rigorous screening, those diagnosed with colon cancer often face poor prognosis, and approximately 70% of affected patients will develop metastatic relapse. The investigation of colon carcinoma cell lines' genetic variability and
Josephine D. Tsang, Cai M. Roberts
wiley   +1 more source

Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. [PDF]

open access: yesJ Nanobiotechnology
Mehdizadeh S   +4 more
europepmc   +1 more source

Neuroinflammatory stress preferentially impacts synaptic MAPK signaling and mitochondria in excitatory neurons. [PDF]

open access: yesMol Neurodegener Adv
Espinosa-Garcia C   +17 more
europepmc   +1 more source

ZO-2 is a scaffold at the centriole and mitotic spindle poles that enhances microtubule stability and supports the proper development of mitotic spindles and cilia. [PDF]

open access: yesCell Tissue Res
Vega-Torreblanca S   +12 more
europepmc   +1 more source

Direct cell-to-cell transmission of retrotransposons

open access: yes
Voichek M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy